Rifaquizinone
Rifaquizinone (CBR-2092) is a Rifamycin-Quinolone Hybrid Antibiotic. Rifaquizinone inhibits wild-type S. aureus RNA polymerase with an IC50 of 34 nM. Rifaquizinone is effective against S. aureus infections, with MICs ranged from 0.008 to 0.5 μg/mL for 300 clinical isolates of staphylococci and streptococci[1][2].
Product Specifications
CAS Number
[922717-97-3]
Product Name Alternative
CBR-2092; TNP-2092
UNSPSC
12352005
Target
Antibiotic; Bacterial; DNA/RNA Synthesis
Type
Reference compound
Related Pathways
Anti-infection; Cell Cycle/DNA Damage
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/rifaquizinone.html
Solubility
10 mM in DMSO
Smiles
Molecular Formula
C65H81FN6O15
Molecular Weight
1205.37
References & Citations
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-135184/Rifaquizinone-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-135184/
Scientific Category
Reference compound1
Clinical Information
Phase 2
Isoform
Quinolone
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items